FDA approves Amgen’s combo therapy for colorectal cancer
The approval is anchored in the outcomes of the Phase III CodeBreaK 300 trial.
Approvals
CDE grants BTD to Innovent’s IBI343 for pancreatic cancer
Lilly gains US FDA approval for Omvoh to treat Crohn’s disease
MSD’s HPV vaccine gains China NMPA’s expanded approval for males
EMA gives OMPD to Actuate’s pancreatic cancer therapy
FDA accepts Sentynl’s Menkes disease therapy NDA for priority review
